Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.9200
+0.0700 (8.24%)
At close: Oct 24, 2025, 4:00 PM EDT
0.9114
-0.0086 (-0.93%)
After-hours: Oct 24, 2025, 7:58 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $19.38 million as of October 24, 2025. Its market cap has decreased by -26.67% in one year.
Market Cap
19.38M
Enterprise Value
10.18M
1-Year Change
-26.67%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $19.38M, a decrease of -88.77%. That is a compound annual growth rate of -37.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 19.38M | -24.51% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | 172.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.08B |
| Johnson & Johnson | 462.74B |
| AbbVie | 403.22B |
| UnitedHealth Group | 326.45B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 219.89B |